Even now, after two decades with collecting detailed knowledge of the approach of using GDNF as a therapeutic agent for PD, the main factors determining GDNF production remains obscure and the question whether GDNF can effectively be used as a therapeutic agent for PD remains unclear (d’Anglemont de Tassigny et al., 2015). The gene discussed is GDNF; the disease is Parkinson disease.